Hunter C. Smith

Hunter C. Smith

Chief Financial OfficeratRhythm Pharmaceuticals· In proxies 2021–2025

Pay in FY2025+23% from the year before · Rhythm Pharmaceuticals stock +91.2% the same year

Hunter C. Smith was paid $6.2M in FY2025 (Dec), up 23%. Rhythm Pharmaceuticals stock rose 91.2% that year.

Pay$100 in the stock at the end of FY20 → $360
Pay is from the Summary Compensation Table of each Rhythm Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rhythm PharmaceuticalsPublic company · 5 yr
    • Chief Financial Officer2021 – Present · 5 yrStock in role +217%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?